Selective Tumor Cell Apoptosis and Tumor Regression in CDH17-Positive Colorectal Cancer Models using BI 905711, a Novel Liver-Sparing TRAILR2 Agonist

Overview of attention for article published in Molecular Cancer Therapeutics, January 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

twitter: 12 X users

patent: 3 patents

Readers on

mendeley: 33 Mendeley

Summary X Patents

So far, Altmetric has seen 3 patents that reference this research output.

BINDING MOLECULES FOR THE TREATMENT OF CANCER

Application WO-2024013315-A1

World Intellectual Property Organisation (WIPO)

TRAILR2 CDH17 binding molecules for the treatment of cancer

Grant US-11851495-B2

United States of America

Multivalent and multispecific DR5-binding fusion proteins and methods of treating…

Grant US-11117973-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.